Avecho Biotechnology has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG for the c...
A peer-reviewed paper detailing the experimental cancer treatment developed by Professor Georgina Long AO, Universi...
It is never lost on me or my team at MTPConnect that there is a paucity of funding allocated to women’s health res...
Australia's University of Queensland (UQ) researchers have developed a new rapid sensor that can detect pregnancy compli...
This formal agreement establishes a collaborative framework between two like-minded, full-service Contract Res...
Trade and Investment Queensland (TIQ), the Queensland Government’s dedicated business agency presented a 20 member...
The Albanese Labor Government is investing $6.7 million to ensure that people with rare cancers can access expert advice...
Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer, key to boosting survival rates...
South Korea-based Coreline Soft, a global leader in artificial intelligence (AI)-based medical solutions, has annou...
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has received the registration of YORVIPATH&...
A $7.5 million philanthropic donation from Dennis Bastas, CEO of DBG Health, will establish a new Health Leadership acad...
The Hunter Medical Research Institute (HMRI) has announced a new partnership with Novartis Australia, formalised through...
The Snow Medical Research Foundation is launching the Snow Vision Accelerator in partnership with the Universi...
Qiagen has announced the official opening of a new data centre in Melbourne, Australia, designed to strengthen its globa...
Smith+Nephew, the global medical technology company, has announced the launch of a comprehensive foot & ankle repair...
Harrison.ai, a leading global healthtech company and developer of artificial intelligence (AI)-powered medical diagnosti...
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimise ...
AdvanCell, a radiopharmaceutical company specialising in targeted alphaherapias, has announced the expansion of the scop...
